Moreover, EGFR overexpression and phosphorylation, which are common mechanisms in epithelial malignancies, are associated with metastasis, chemotherapy resistance, and poor prognosis, making it a promising target for cancer therapy (Nicholson et al. 2001). Here, EGFR is linked to cancer.